Chromium picolonate
Searched over 200M research papers for "chromium picolonate"
Summary
10 papers analyzed
Some studies suggest chromium picolinate improves insulin sensitivity, glycemic control, and lipid profiles in certain populations, while other studies indicate it does not affect weight loss, body composition, or insulin sensitivity in healthy, nonobese individuals.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta19 papers analyzed
Chromium Picolinate: Benefits and Effects
Chromium Picolinate and Insulin Sensitivity
Chromium picolinate (CrPic) has been extensively studied for its potential to enhance insulin sensitivity. Research indicates that CrPic supplementation can improve insulin receptor signaling, which is crucial for glucose metabolism. In obese, insulin-resistant rats, CrPic significantly increased insulin-stimulated phosphorylation of insulin receptor substrate-1 and phosphatidylinositol-3 kinase activity in skeletal muscle, leading to improved glucose disposal rates. Additionally, CrPic was shown to reduce fasting insulin levels and enhance glucose disappearance in obese hyperinsulinemic rats, suggesting its efficacy in improving insulin sensitivity.
Chromium Picolinate and Glycemic Control in Diabetes
Clinical studies have demonstrated that CrPic supplementation can be beneficial for individuals with diabetes. A review of 15 clinical studies involving 1,690 subjects found that CrPic significantly improved glycemic control, reducing blood glucose and insulin levels, as well as cholesterol and triglyceride levels. These findings suggest that CrPic can be a valuable supplement for managing diabetes and associated dyslipidemia.
Chromium Picolinate and Weight Loss
The potential of CrPic as a weight loss aid has also been explored. However, a randomized, double-blind, placebo-controlled trial involving 80 overweight adults found no significant effect of CrPic supplementation on body mass index (BMI) or central adiposity over a 24-week period. This suggests that while CrPic may have other metabolic benefits, its efficacy as a weight loss supplement is limited.
Chromium Picolinate and Lipid Metabolism
CrPic has shown promise in improving lipid profiles. In a study on non-alcoholic fatty liver disease (NAFLD) patients, CrPic supplementation significantly reduced triglycerides, very-low-density lipoprotein (VLDL), and inflammatory markers, while increasing insulin sensitivity. Similarly, in obese rats, CrPic lowered total cholesterol and increased high-density lipoprotein (HDL) cholesterol levels. These results indicate that CrPic can positively influence lipid metabolism, which is beneficial for cardiovascular health.
Chromium Picolinate and Body Composition
The effects of CrPic on body composition have been mixed. In a study involving healthy, non-obese older adults, CrPic supplementation did not result in significant changes in body composition, serum lipids, or insulin sensitivity. Conversely, in broiler chicks, CrPic supplementation improved body weight and feed conversion efficiency, suggesting a potential role in enhancing growth performance in animals.
Safety and Toxicity of Chromium Picolinate
Long-term studies on the safety of CrPic have shown that it does not induce significant toxicity or carcinogenicity. A two-year study on rats and mice exposed to various concentrations of CrPic monohydrate found no biologically significant changes in survival, body weight, or non-neoplastic lesions, indicating that CrPic is safe for long-term use.
Conclusion
Chromium picolinate has demonstrated various metabolic benefits, particularly in enhancing insulin sensitivity and improving lipid profiles. While its efficacy as a weight loss supplement is questionable, it holds promise for managing diabetes and associated dyslipidemia. Long-term studies affirm its safety, making it a viable option for individuals seeking to improve their metabolic health.
Sources and full results
Most relevant research papers on this topic
